Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
04/02/2003 | EP1296931A2 Polyamine analogues as cytotoxic agents |
04/02/2003 | EP1296716A2 New formulation |
04/02/2003 | EP1296699A1 Therapeutic agents - iii |
04/02/2003 | EP1296698A1 Therapeutic agents - ii |
04/02/2003 | EP1296697A1 Therapeutic agents - i |
04/02/2003 | EP1296687A2 Treatment of male sexual dysfunction |
04/02/2003 | EP1206453B1 Process for the preparation of 3,5-dichloropyridine |
04/02/2003 | EP1204668B1 Bisimidino compounds and the transitional metal complexes thereof as well as the use thereof as catalysts |
04/02/2003 | EP1030842B1 Metalloproteinase inhibitors |
04/02/2003 | EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
04/02/2003 | EP0873295B1 Dimer-selective rxr modulators and methods for their use |
04/02/2003 | EP0741694B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them |
04/02/2003 | CN1407971A Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
04/02/2003 | CN1104417C Method for preparing 1,1'-dialkyl-bipyridyl salt containing no cyanogen ion |
04/02/2003 | CN1104413C Phenylalkylcarboxylic acid derivatives |
04/02/2003 | CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them |
04/01/2003 | US6541674 Electron-withdrawing group present on carbonyl compound is selected from fluoroalkyl derivatives, esters, including orthoesters, and nitrites and condensation is carried out in basic medium |
04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
04/01/2003 | US6541661 Inhibitors of histone deacetylase |
04/01/2003 | US6541655 Catalytic compositions and methods for asymmetric allylic alkylation |
04/01/2003 | US6541645 Electron-driven chirality switches |
04/01/2003 | US6541640 Process for the preparation of 4-haloalkylnicotinonitriles |
04/01/2003 | US6541632 Process for producing heterocyclic nitriles |
04/01/2003 | US6541521 Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
04/01/2003 | US6541490 Treating ischemia or reoxygenation injury; preparation from a bipyridine, a benzeneboronic acid and a manganese salt |
04/01/2003 | US6541475 2-nitrostyryl-1-(naphthylmethyl)sulfone for example |
04/01/2003 | US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
04/01/2003 | US6541473 Resorcinol derivatives |
04/01/2003 | US6540793 Coupler for use in oxidative hair dyeing |
03/28/2003 | CA2405328A1 Process for preparing alkanesulfonyl pyridines |
03/27/2003 | WO2003024955A2 Small molecule inhibitors of caspases |
03/27/2003 | WO2003024946A2 Oxamate derivatives containing a variously substituted nitrogen heterocycle |
03/27/2003 | WO2003024933A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
03/27/2003 | WO2003024923A1 Sulfonamide compounds as protease inhibitors |
03/27/2003 | WO2003024920A1 Substituted urea retinoid agonists ii |
03/27/2003 | WO2003024913A1 SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING NF-κB INHIBITING ACTIVITY |
03/27/2003 | WO2003024529A1 Simplified sarcodictyn derivatives as anti-tumor agents |
03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
03/27/2003 | WO2003024441A1 Novel use of tricyclic compound |
03/27/2003 | WO2003024439A1 Phenethanolamine derivatives for treatment of respiratory diseases |
03/27/2003 | WO2003024395A2 Linked biaryl compounds |
03/27/2003 | WO2002098854A3 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
03/27/2003 | WO2002060879A3 Bacterial gyrase inhibitors and uses thereof |
03/27/2003 | WO2002048111A3 Method for producing 4-haloalkyl nicotine nitriles |
03/27/2003 | WO2002042262A3 Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber |
03/27/2003 | WO2002014261A3 4-substituted d-glutamic acid derivatives for use as antibiotic |
03/27/2003 | WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents |
03/27/2003 | WO2001070685A3 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
03/27/2003 | US20030060625 Para-amine substituted phenylamide glucokinase activators |
03/27/2003 | US20030060491 Bicyclic aromatic compounds |
03/27/2003 | US20030060472 Inhibitor of the enzyme catechol-O-methyl transferase (COMT) |
03/27/2003 | US20030060470 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparation comprising them |
03/27/2003 | US20030060460 Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient |
03/27/2003 | US20030060459 Diamines as modulators of chemokine receptor activity |
03/27/2003 | US20030060455 Treating lung damage from smoke, endometriosis, Behcet's disease, ankylosing spondylitis, cancer, Lyme disease, and/or restenosis following agioplasty with 1-(4-t-butyl-phenyl)-3-(4-(6-morpholin-4-ylmethyl-peperidin-yl)naphthalen-1 -yl)-urea |
03/27/2003 | US20030060452 N-heterocyclic derivatives as NOS inhibitors |
03/27/2003 | US20030060419 Used to treat stroke, cerebral ischemia, pain, head trauma, asthma, amyotropic lateral sclerosis, or epilepsy |
03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
03/27/2003 | CA2460244A1 Simplified sarcodictyn derivatives as anti-tumor agents |
03/27/2003 | CA2460149A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
03/27/2003 | CA2429005A1 Substituted benzoic acid derivatives having nf-kb inhibiting action |
03/26/2003 | EP1296142A2 Calcium receptor active molecules |
03/26/2003 | EP1295878A1 Novel pyrazinone derivatives |
03/26/2003 | EP1295868A1 Amide compounds and use thereof |
03/26/2003 | EP1295867A1 Biphenyl compound |
03/26/2003 | EP1295607A1 Antitumor effect potentiators |
03/26/2003 | EP1295514A2 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
03/26/2003 | EP1294704A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
03/26/2003 | EP1294695A2 Substituted diamide derivatives useful as motilin antagonists |
03/26/2003 | EP1294693A1 Hydroxypyridone methide azo dyes |
03/26/2003 | EP1294692A1 New process |
03/26/2003 | EP1294691A1 Serine protease inhibitors |
03/26/2003 | EP1294687A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
03/26/2003 | EP1294684A2 THROMBIN OR FACTOR Xa INHIBITORS |
03/26/2003 | EP1294677A1 Benzophenones and sulfones as inhibitors of glycine uptake |
03/26/2003 | EP1294662A1 Processes for fluorinating aromatic ring compounds |
03/26/2003 | EP1294482A2 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins |
03/26/2003 | EP1294378A2 Thrombopoietin mimetics |
03/26/2003 | EP1294366A1 Pharmaceutical compounds for treating copd |
03/26/2003 | EP1294362A1 Novel process for preparing crystalline particles |
03/26/2003 | EP1095930B1 Novel compounds |
03/26/2003 | EP1025085B1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof |
03/26/2003 | EP0977735B1 Vitronectin receptor antagonists |
03/26/2003 | EP0804418B1 Platelet aggregation inhibitors |
03/26/2003 | EP0801640B1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
03/26/2003 | CN1406226A Novel malonic acid derivatives, process for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them |
03/26/2003 | CN1405158A Method for preparing substituted oxazole |
03/26/2003 | CN1405154A N-hydroxy amidino compound preparation method |
03/26/2003 | CN1404923A Super-nucleophilic 4-substituted-pyridine catalyst and preparation method thereof |
03/26/2003 | CN1103771C Method for preparing 1-(2-pyridyl) Pyrazole compound |
03/26/2003 | CN1103759C Processes for preparing pesticidal intermediates |
03/26/2003 | CN1103758C Process for preparation of drylamides of heteroaromatic carboxylic acids |
03/26/2003 | CN1103757C Method for synthesizing 4-trifluoromethyl pyridine compound |
03/25/2003 | US6538149 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
03/25/2003 | US6538139 Preparation of pyrrole and pyridine |
03/25/2003 | US6538138 Process and a novel intermediate for the preparation of Flecainide |
03/25/2003 | US6538031 Method of controlling sea lice infestation in fish |
03/25/2003 | US6538013 Acyclic and cyclic guanidine-and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
03/25/2003 | US6538010 Compounds may be used to treat a variety of other conditions and disease states and reagents for preventing smoking addiction. The present invention also relates to methods and reagents for treating nicotine addiction. |
03/25/2003 | US6537996 Substituted pyridine or pyrimidine derivatives |